Advertisement

Topics

Onyx Pharmaceuticals, Inc. Company Profile

18:08 EDT 25th September 2017 | BioPortfolio

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar® (sorafenib) tablets, a small molecule drug that is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. Beyond Nexavar, Onyx has established a development pipeline of anticancer compounds at various stages of clinical testing, including carfilzomib, a next-generation proteasome inhibitor, that is currently being evaluated in multiple clinical trials for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors. ONX 0801, a targeted alpha-folate inhibitor, and ONX 0912, an oral proteasome inhibitor, are currently in Phase 1 testing. For more information about Onyx, visit the company's website at www.onyx-pharm.com.


News Articles [1271 Associated News Articles listed on BioPortfolio]

Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results Teleconference and Webcast

SAN FRANCISCO, Feb. 9, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will host a webcast and teleconference with management to discuss fourth quarter and full ...

Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 3, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at two healthcare conferences in November. Credit Suisse 2011 A...

Medtronic announces Japanese launch of Resolute Onyx drug-eluting stent

Medtronic is launching its Resolute Onyx drug-eluting stent in Japan today.  -More- 

Onyx Pharmaceuticals Announces Cell Publication Demonstrating Selectivity of Immunoproteasome Inhibitor ONX 0914

SOUTH SAN FRANCISCO, Calif., March 29, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the publication of an article in Cell, describing the crystal structures of two fo...

Onyx Helps Accelerate TopiVert???s Compounds To Clinic

  Life Sciences Jobs   ...

Onyx Health wins OLM Diagnostics account

Will develop a marketing strategy for the UK-based firm

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.

Medtronic RESOLUTE ONYX 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

  Life Sciences Jobs   ...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [165 Associated PubMed Articles listed on BioPortfolio]

Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial.

To assess the safety and efficacy of the novel Resolute (R-) Onyx drug-eluting stent (DES).

A Case Report of Onyx Pulmonary Arterial Embolism Contributing to Hypoxemia During Awake Craniotomy for Arteriovenous Malformation Resection.

A healthy 26-year-old man with cerebral arteriovenous malformation underwent staged endovascular embolization with Onyx followed by awake craniotomy for resection. The perioperative course was complic...

Cognard Type V Dural Arteriovenous Fistula Involving the Occipital Sinus.

The Cognard type V dural arteriovenous fistula (dAVF), which has a drainage route into the spinal vein, is a rare subtype of cranial dAVF. Because of typical features such as progressive myelopathy an...

Safety of Onyx Transarterial Embolization of Skull Base Dural Arteriovenous Fistulas from Meningeal Branches of the External Carotids also Fed by Meningeal Branches of Internal Carotid or Vertebral Arteries.

To analyze the angiographic and clinical results of transarterial embolization with Onyx (Medtronic-Covidien, Irvine, CA) in dural arteriovenous fistulas (DAVFs) partially fed by arteries arising from...

Direct stick embolization of extremity arteriovenous malformations with ethylene vinyl alcohol copolymer.

Direct stick embolization (DSE) of high-flow peripheral arteriovenous malformations (AVMs) has previously been reported using n-butyl cyanoacrylate and ethanol. The use of ethylene vinyl alcohol copo...

Clinical Trials [207 Associated Clinical Trials listed on BioPortfolio]

IRIS-Onyx Cohort in the IRIS-DES Registry

The purpose of this study is to evaluate the relative effectiveness and safety of Onyx stent compared to other (drug eluting stents) DES.

Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis

The objectives of this study are 1. To establish a prospective registry of the whole patients who received percutaneous coronary intervention with Resolute Onyx™ stent. ...

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

RATIONALE: A specially modified virus called ONYX-015 may be able to kill tumor cells while leaving normal cells undamaged. Drugs used in chemotherapy use different ways to stop tumor cell...

Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)

Test whether AVMs treated with Onyx is equivalent to treatment with n-BCA. Success is defined as an AVM size reduction greater than 50%

RESOLUTE ONYX Post-Approval Study

To observe the continued performance of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in a real-world more-comer population.

Companies [1283 Associated Companies listed on BioPortfolio]

Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developi...

Onyx Pharmaceuticals

Onyx Pharmaceuticals, Inc. is engaged in the discovery and development of novel therapeutics based upon the genetics of human disease, with an emphasis on cancer. The Company's strategy is to capitali...

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc.

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3

Onyx Scientific Limited

Onyx Scientific is one of the fastest growing pharmaceutical service companies in the UK. We have more than 40 expert scientists specialising in drug development from medicinal chemistry to early stag...

Onyx Environmental Services

Onyx Environmental Services is the leading provider of environmental services in the United States. Our network of service centers, treatment, recovery and disposal facilities, sales offices and trans...

More Information about "Onyx Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Onyx Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Onyx Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Onyx Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Onyx Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Onyx Pharmaceuticals, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record